Sendai virus-mediated gene transfer of GDNF reduces AIF translocation and ameliorates ischemic cerebral injury

Guang Jin, Makoto Inoue, Takeshi Hayashi, Kentaro Deguchi, Shoko Nagotani, Hanzhe Zhang, Xiquan Wang, Mikio Shoji, Mamoru Hasegawa, Koji Abe

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The therapeutic effect of a novel RNA viral vector, Sendai virus (SeV)-mediated glial cell line-derived neurotrophic factor (GDNF) gene (SeV/CDNF), on the infarct volume, was investigated after 90 minutes of transient middle cerebral artery occlusion (tMCAO) in rats with relation to nuclear translocation of apoptosis inducing factor (AIF). The topical administration of SeV/CDNF induced high level expression of GDNF protein, which effectively reduced the infarct volume when administrated 0 and 1 hours as well after the reperfusion. Twenty-four hours after ischemia, the obvious nuclear translocation of AIF was found in neurons of peri-infarct area, which significantly reduced with administration of SeV/CDNF 0 or 1 hour after reperfusion, as well as the number of TUNEL positive cells. These results demonstrate that SeV vector-mediated gene transfer of GDNF effectively reduced ischemic infarct volume after tMCAO and extended the therapeutic time window compared with previous viral vectors, and that promoting neuronal survival of GDNF might be related to the reduction of AIF nuclear translocation, indicating the high therapeutic potency of SeV/GDNF for cerebral ischemia.

Original languageEnglish
Pages (from-to)731-739
Number of pages9
JournalNeurological Research
Volume30
Issue number7
DOIs
Publication statusPublished - Sep 2008

Fingerprint

Apoptosis Inducing Factor
Glial Cell Line-Derived Neurotrophic Factor
Sendai virus
Wounds and Injuries
Genes
Middle Cerebral Artery Infarction
Reperfusion
Topical Administration
In Situ Nick-End Labeling
Viral RNA
Therapeutic Uses
Brain Ischemia
Ischemia
Neurons
Therapeutics

Keywords

  • Apoptosis inducing factor
  • Focal cerebral ischemia
  • Glial cell line-derived neurotrophic factor
  • Sendai virus vector

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Sendai virus-mediated gene transfer of GDNF reduces AIF translocation and ameliorates ischemic cerebral injury. / Jin, Guang; Inoue, Makoto; Hayashi, Takeshi; Deguchi, Kentaro; Nagotani, Shoko; Zhang, Hanzhe; Wang, Xiquan; Shoji, Mikio; Hasegawa, Mamoru; Abe, Koji.

In: Neurological Research, Vol. 30, No. 7, 09.2008, p. 731-739.

Research output: Contribution to journalArticle

Jin, G, Inoue, M, Hayashi, T, Deguchi, K, Nagotani, S, Zhang, H, Wang, X, Shoji, M, Hasegawa, M & Abe, K 2008, 'Sendai virus-mediated gene transfer of GDNF reduces AIF translocation and ameliorates ischemic cerebral injury', Neurological Research, vol. 30, no. 7, pp. 731-739. https://doi.org/10.1179/174313208X305418
Jin, Guang ; Inoue, Makoto ; Hayashi, Takeshi ; Deguchi, Kentaro ; Nagotani, Shoko ; Zhang, Hanzhe ; Wang, Xiquan ; Shoji, Mikio ; Hasegawa, Mamoru ; Abe, Koji. / Sendai virus-mediated gene transfer of GDNF reduces AIF translocation and ameliorates ischemic cerebral injury. In: Neurological Research. 2008 ; Vol. 30, No. 7. pp. 731-739.
@article{0b3f6547d06e49bebec29b2a77e0cd8b,
title = "Sendai virus-mediated gene transfer of GDNF reduces AIF translocation and ameliorates ischemic cerebral injury",
abstract = "The therapeutic effect of a novel RNA viral vector, Sendai virus (SeV)-mediated glial cell line-derived neurotrophic factor (GDNF) gene (SeV/CDNF), on the infarct volume, was investigated after 90 minutes of transient middle cerebral artery occlusion (tMCAO) in rats with relation to nuclear translocation of apoptosis inducing factor (AIF). The topical administration of SeV/CDNF induced high level expression of GDNF protein, which effectively reduced the infarct volume when administrated 0 and 1 hours as well after the reperfusion. Twenty-four hours after ischemia, the obvious nuclear translocation of AIF was found in neurons of peri-infarct area, which significantly reduced with administration of SeV/CDNF 0 or 1 hour after reperfusion, as well as the number of TUNEL positive cells. These results demonstrate that SeV vector-mediated gene transfer of GDNF effectively reduced ischemic infarct volume after tMCAO and extended the therapeutic time window compared with previous viral vectors, and that promoting neuronal survival of GDNF might be related to the reduction of AIF nuclear translocation, indicating the high therapeutic potency of SeV/GDNF for cerebral ischemia.",
keywords = "Apoptosis inducing factor, Focal cerebral ischemia, Glial cell line-derived neurotrophic factor, Sendai virus vector",
author = "Guang Jin and Makoto Inoue and Takeshi Hayashi and Kentaro Deguchi and Shoko Nagotani and Hanzhe Zhang and Xiquan Wang and Mikio Shoji and Mamoru Hasegawa and Koji Abe",
year = "2008",
month = "9",
doi = "10.1179/174313208X305418",
language = "English",
volume = "30",
pages = "731--739",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "7",

}

TY - JOUR

T1 - Sendai virus-mediated gene transfer of GDNF reduces AIF translocation and ameliorates ischemic cerebral injury

AU - Jin, Guang

AU - Inoue, Makoto

AU - Hayashi, Takeshi

AU - Deguchi, Kentaro

AU - Nagotani, Shoko

AU - Zhang, Hanzhe

AU - Wang, Xiquan

AU - Shoji, Mikio

AU - Hasegawa, Mamoru

AU - Abe, Koji

PY - 2008/9

Y1 - 2008/9

N2 - The therapeutic effect of a novel RNA viral vector, Sendai virus (SeV)-mediated glial cell line-derived neurotrophic factor (GDNF) gene (SeV/CDNF), on the infarct volume, was investigated after 90 minutes of transient middle cerebral artery occlusion (tMCAO) in rats with relation to nuclear translocation of apoptosis inducing factor (AIF). The topical administration of SeV/CDNF induced high level expression of GDNF protein, which effectively reduced the infarct volume when administrated 0 and 1 hours as well after the reperfusion. Twenty-four hours after ischemia, the obvious nuclear translocation of AIF was found in neurons of peri-infarct area, which significantly reduced with administration of SeV/CDNF 0 or 1 hour after reperfusion, as well as the number of TUNEL positive cells. These results demonstrate that SeV vector-mediated gene transfer of GDNF effectively reduced ischemic infarct volume after tMCAO and extended the therapeutic time window compared with previous viral vectors, and that promoting neuronal survival of GDNF might be related to the reduction of AIF nuclear translocation, indicating the high therapeutic potency of SeV/GDNF for cerebral ischemia.

AB - The therapeutic effect of a novel RNA viral vector, Sendai virus (SeV)-mediated glial cell line-derived neurotrophic factor (GDNF) gene (SeV/CDNF), on the infarct volume, was investigated after 90 minutes of transient middle cerebral artery occlusion (tMCAO) in rats with relation to nuclear translocation of apoptosis inducing factor (AIF). The topical administration of SeV/CDNF induced high level expression of GDNF protein, which effectively reduced the infarct volume when administrated 0 and 1 hours as well after the reperfusion. Twenty-four hours after ischemia, the obvious nuclear translocation of AIF was found in neurons of peri-infarct area, which significantly reduced with administration of SeV/CDNF 0 or 1 hour after reperfusion, as well as the number of TUNEL positive cells. These results demonstrate that SeV vector-mediated gene transfer of GDNF effectively reduced ischemic infarct volume after tMCAO and extended the therapeutic time window compared with previous viral vectors, and that promoting neuronal survival of GDNF might be related to the reduction of AIF nuclear translocation, indicating the high therapeutic potency of SeV/GDNF for cerebral ischemia.

KW - Apoptosis inducing factor

KW - Focal cerebral ischemia

KW - Glial cell line-derived neurotrophic factor

KW - Sendai virus vector

UR - http://www.scopus.com/inward/record.url?scp=51649112434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51649112434&partnerID=8YFLogxK

U2 - 10.1179/174313208X305418

DO - 10.1179/174313208X305418

M3 - Article

C2 - 18593521

AN - SCOPUS:51649112434

VL - 30

SP - 731

EP - 739

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 7

ER -